SynOV1.1
/ SyngenTech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2026
Clinical study of SynOV1.1 adenovirus injection for the treatment of solid tumors with high alpha-fetoprotein levels
(ChiCTR)
- P=N/A | N=18 | Not yet recruiting | Sponsor: Langfang Campus of Chinese Academy of Medical Sciences Cancer Hospital; Langfang Campus of Chinese Academy of Medical Sciences Cancer Hospital
New trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1